Advertisement

Digestive Diseases and Sciences

, Volume 63, Issue 2, pp 502–514 | Cite as

Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern

  • Xiaoyun Zhang
  • Chuan Li
  • Tianfu Wen
  • Wei Peng
  • Lunan Yan
  • Jiayin Yang
Original Article

Abstract

Background

The treatment of intrahepatic recurrent hepatocellular carcinoma (HCC) has been poorly investigated, and the optimal treatment strategy remains unclear.

Aims

The aim of this study was to compare outcomes between salvage liver transplantation (SLT) and re-resection (RR)/radiofrequency ablation (RFA) for intrahepatic recurrent HCC according to recurrence pattern.

Methods

Based on postoperative histopathological examination, 122 patients with intrahepatic recurrent HCC were divided into an intrahepatic metastasis (IM, n = 75) group and a multicentric occurrence (MO, n = 47) group. The demographic, clinical, and primary and recurrent tumor characteristics of the IM group and the MO group were collected and compared. Overall survival (OS) and disease-free survival (DFS) were analyzed, and subgroup analysis according to retreatment type (SLT vs. RR/RFA) was conducted. Twenty-nine clinicopathological variables potentially related to prognostic factors affecting survival were analyzed using a Cox proportional hazard model.

Results

The patients that received SLT treatment exhibited favorable DFS compared to patients that received RR/RFA (P = 0.002). OS (P < 0.001) and DFS (P = 0.008) rates were significantly increased in the MO group compared with in the IM group. Subgroup analysis revealed that DFS was significantly improved for patients in the MO group treated with SLT compared to patients treated with RR/RFA (P = 0.017). Recurrence pattern was an independent prognostic factor for both OS [hazard ratio (HR) = 0.093, 95% confidence interval (CI): 0.026–0.337, P < 0.001] and DFS (HR = 0.318, 95% CI: 0.125–0.810, P = 0.016; HR = 3.334, 95% CI: 1.546–7.18, P = 0.002).

Conclusions

For patients with intrahepatic recurrent HCC, an MO recurrence pattern is associated with better long-term outcomes than the IM pattern. SLT is the preferred option for intrahepatic recurrent HCC, especially for MO cases.

Keywords

Intrahepatic recurrence Intrahepatic metastasis Multicentric occurrence Salvage liver transplantation Re-resection Radiofrequency ablation 

Notes

Acknowledgments

This work was in part supported by Grant from the National Science and Technology Key Projects (2017ZX10203207-003-002) and Scientific and Technological Support Project of Sichuan Province (2016SZ0025 and 2015SZ0049).

Compliance with ethical standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Supplementary material

10620_2017_4861_MOESM1_ESM.docx (32 kb)
Supplementary material 1 (DOCX 31 kb)

References

  1. 1.
    Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  2. 2.
    Bruix J, Sherman M. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–1022.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–943.CrossRefGoogle Scholar
  4. 4.
    Fan ST, Mau Lo C, Poon RT, et al. Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg. 2011;253:745–758.CrossRefPubMedGoogle Scholar
  5. 5.
    Regimbeau JM, Abdalla EK, Vauthey JN, et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;85:36–41.CrossRefPubMedGoogle Scholar
  6. 6.
    Chen Y-J, Yeh S-H, Chen J-T, et al. Chromosomal changes and clonality relationship between primary and recurrent hepatocellular carcinoma. Gastroenterology. 2000;119:431–440.CrossRefPubMedGoogle Scholar
  7. 7.
    Morimoto O, Nagano H, Sakon M, et al. Diagnosis of intrahepatic metastasis and multicentric carcinogenesis by microsatellite loss of heterozygosity in patients with multiple and recurrent hepatocellular carcinomas. J Hepatol. 2003;39:215–221.CrossRefPubMedGoogle Scholar
  8. 8.
    Baffy G. Decoding multifocal hepatocellular carcinoma: an opportune pursuit. Hepatobiliary Surg Nutr. 2015;4:206–210.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Li Q, Wang J, Juzi JT, et al. Clonality analysis for multicentric origin and intrahepatic metastasis in recurrent and primary hepatocellular carcinoma. J Gastrointest Surg. 2008;12:1540–1547.CrossRefPubMedGoogle Scholar
  10. 10.
    Wang B, Xia CY, Lau WY, et al. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery. J Am Coll Surg. 2013;217:1054–1062.CrossRefPubMedGoogle Scholar
  11. 11.
    Matsuda M, Fujii H, Kono H, Matsumoto Y. Surgical treatment of recurrent hepatocellular carcinoma based on the mode of recurrence: repeat hepatic resection or ablation are good choices for patients with recurrent multicentric cancer. J Hepato-Biliary-Pancreatic Surg. 2001;8:353–359.CrossRefGoogle Scholar
  12. 12.
    Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis. Hepatology. 2012;55:132–140.CrossRefPubMedGoogle Scholar
  13. 13.
    Chan AC, Chan SC, Chok KS, et al. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation? Liver Transplant. 2013;19:411–419.CrossRefGoogle Scholar
  14. 14.
    Yamashita Y, Yoshida Y, Kurihara T, et al. Surgical results for recurrent hepatocellular carcinoma after curative hepatectomy: Repeat hepatectomy versus salvage living donor liver transplantation. Liver Transplant. 2015;21:961–968.CrossRefGoogle Scholar
  15. 15.
    Hao S, Fan P, Chen S, Tu C, Wan C. Distinct recurrence risk factors for intrahepatic metastasis and multicenter occurrence after surgery in patients with hepatocellular Carcinoma. J Gastrointest Surg. 2017;21:312–320.CrossRefPubMedGoogle Scholar
  16. 16.
    Zhang XY, Li C, Wen TF, et al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur J Gastroenterol Hepatol. 2015;27:933–940.CrossRefPubMedGoogle Scholar
  17. 17.
    Arii S, Monden K, Niwano M, et al. Results of surgical treatment for recurrent hepatocellular carcinoma; comparison of outcome among patients with multicentric carcinogenesis, intrahepatic metastasis, and extrahepatic recurrence. J Hepato-Biliary-Pancreatic Surg. 1998;5:86–92.CrossRefGoogle Scholar
  18. 18.
    Kumada T, Nakano S, Takeda I, et al. Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology. 1997;25:87–92.CrossRefPubMedGoogle Scholar
  19. 19.
    Zhang X, Li C, Wen T, et al. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern. Eur J Gastroenterol Hepatol. 2015;27:933–940.CrossRefPubMedGoogle Scholar
  20. 20.
    Huang J, Yan L, Cheng Z, et al. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria. Ann Surg. 2010;252:903–912.CrossRefPubMedGoogle Scholar
  21. 21.
    Jiang L, Yan L, Li B, et al. Prophylaxis against hepatitis B recurrence posttransplantation using lamivudine and individualized low-dose hepatitis B immunoglobulin. Am J Transplant. 2010;10:1861–1869.CrossRefPubMedGoogle Scholar
  22. 22.
    Li C, Mi K, Wen T, et al. A learning curve for living donor liver transplantation. Dig Liver Dis. 2012;44:597–602.CrossRefPubMedGoogle Scholar
  23. 23.
    Li C, Zhu WJ, Wen TF, et al. Child-Pugh A hepatitis B-related cirrhotic patients with a single hepatocellular carcinoma up to 5 cm: liver transplantation vs. resection. J Gastrointest Surg. 2014;18:1469–1476.CrossRefPubMedGoogle Scholar
  24. 24.
    Takenaka K, Adachi E, Nishizaki T, et al. Possible multicentric occurrence of hepatocellular carcinoma: a clinicopathological study. Hepatology. 1994;19:889–894.CrossRefPubMedGoogle Scholar
  25. 25.
    Saeki R, Nagai H, Kaneko S, et al. Intratumoral genomic heterogeneity in human hepatocellular carcinoma detected by restriction landmark genomic scanning. J Hepatol. 2000;33:99–105.CrossRefPubMedGoogle Scholar
  26. 26.
    Friemel J, Rechsteiner M, Frick L, et al. Intratumor heterogeneity in hepatocellular carcinoma. Clin Cancer Res. 2015;21:1951–1961.CrossRefPubMedGoogle Scholar
  27. 27.
    Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507.CrossRefPubMedGoogle Scholar
  28. 28.
    Jin YJ, Lee JW, Lee OH, et al. Transarterial chemoembolization versus surgery/radiofrequency ablation for recurrent hepatocellular carcinoma with or without microvascular invasion. J Gastroenterol Hepatol. 2014;29:1056–1064.CrossRefPubMedGoogle Scholar
  29. 29.
    Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation in patients with single, small hepatocellular carcinoma and preserved liver function: an outcome-oriented decision analysis. Hepatology. 2000;31:899–906.CrossRefPubMedGoogle Scholar
  30. 30.
    Ferrer-Fabrega J, Forner A, Liccioni A, et al. Prospective validation of ab initio liver transplantation in hepatocellular carcinoma upon detection of risk factors for recurrence after resection. Hepatology. 2016;63:839–849.CrossRefPubMedGoogle Scholar
  31. 31.
    Hu Z, Wang W, Li Z, Ye S, Zheng SS. Recipient outcomes of salvage liver transplantation versus primary liver transplantation: a systematic review and meta-analysis. Liver Transplant. 2012;18:1316–1323.CrossRefGoogle Scholar
  32. 32.
    Imamura H, Matsuyama Y, Tanaka E, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–207.CrossRefPubMedGoogle Scholar
  33. 33.
    Du Z-G, Wei Y-G, Chen K-F, Li B. Risk factors associated with early and late recurrence after curative resection of hepatocellular carcinoma: a single institution’s experience with 398 consecutive patients. Hepatobiliary Pancreatic Dis Int. 2014;13:153–161.CrossRefGoogle Scholar
  34. 34.
    Cheng Z, Yang P, Qu S, et al. Risk factors and management for early and late intrahepatic recurrence of solitary hepatocellular carcinoma after curative resection. HPB. 2015;17:422–427.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2017

Authors and Affiliations

  1. 1.Department of Liver Surgery and Liver Transplantation CenterWest China Hospital of Sichuan UniversityChengduChina

Personalised recommendations